The European Commission and the Circular Bio-based Europe Joint Undertaking (CBE JU) are establishing a Bioeconomy Investment Deployment Group (BIDG) to support financing for Europe’s bio-based industries. The initiative is intended to reduce investment risks, define funding standards, and combine public and private capital.
According to the Commission, Europe’s bioeconomy already supports around 17 million jobs and generates up to €2.7 trillion in economic value. However, it notes that many bio-based projects face difficulties securing funding at key stages, particularly when scaling from pilot to industrial production. The Commission indicates that this gap may limit the region’s ability to translate advances in biotechnology and sustainable materials into industrial applications.
To address this, the Commission and CBE JU have brought together banks, national promotional institutions, venture capital funds, and institutional investors. An event held in Brussels this week marked the start of the process, ahead of the group’s first plenary meeting scheduled for June 2026. A work plan covering 2026–2029 will be submitted to the CBE JU Governing Board.
To prevent valley of death during project financing
A recent study by the European Investment Bank Group, titled Scaling up Europe’s bio-based industries, highlights structural financing gaps at capital-intensive stages such as pilot-to-demonstration and first-of-a-kind industrial deployment.
The study notes that conventional project finance often underestimates risk at these stages, while venture capital and grant funding may be insufficient. This creates what the report describes as a “valley of death” for projects moving toward commercialization.
Instead of just talking about solutions, the BIDG will focus on four key areas that match the funding process:
- Designing better financing instruments: The work will be on blended-finance architectures, risk-sharing facilities and guarantee instruments tailored to long-duration bio-based projects. It will feed directly into the design of future EU financing frameworks, including instruments under the European Competitiveness Fund, Scale Up Fund and other EU funding instruments.
- Building a bankable project pipeline: The Deployment Group will develop a common understanding of project bankability aspects, shared due diligence standards, and governance for a database of investment-ready projects. The objective is to shorten origination cycles and enable the formation of financing consortia for large-ticket first-of-a-kind deployments.
- Improve transparency by monitoring and reporting: The work will include a digital eligibility checker aligned with existing sustainability and taxonomy frameworks, together with methodologies for tracking capital flows into the sector, addressing a persistent data gap that has hindered portfolio construction and benchmarking.
- Connecting industry and investors: Linking bio-based scale-ups with financial institutions and corporates matched by ticket size, risk appetite and sectoral focus will be the focus of the workstream.
What investors and banks called for
The discussions during this week’s meeting highlighted three priorities that will shape the work plan:
- Standardized contracts and criteria: Simplifying documents and agreements to make it easier for multiple investors to team up.
- Long-term, patient funding: Recognizing that bio-based industrial projects typically require more time and layered risk mitigation than conventional green-finance projects.
- Visibility and signaling: More communication on Europe’s bioeconomy plans as emerging from the EU Bioeconomy Strategy and the forthcoming Biotech Act II.
Who’s involved and who’s missing
The group already includes the European Investment Bank Group, national promotional banks, specialist venture and growth-equity funds with mandates in industrial decarbonization.
The breadth of interest reflects a shared recognition that no single institution can carry the sector alone, and that coordinated action is the fastest route to deployable capital.
However, key segments of the European financial ecosystem remain underrepresented at this stage. Participation from national promotional banks beyond early frontrunners remains uneven, while large commercial banks have yet to engage at scale on bio-based industrial deployment.
Equally, major institutional investors, notably pension funds and insurance companies, are not yet present, despite their capacity to provide the long-term, patient capital required for first-of-a-kind projects.
Expanding participation from these institutions will be crucial to unlocking the billions in private investment required to grow Europe’s bioeconomy.
Next steps
- June 2026: First plenary meeting to develop the 2026–2029 work plan
- 2026–2029: Delivery of the agreed work plan
Financial institutions interested in participating in the Deployment Group are invited to engage with the Commission ahead of the first meeting by email: ENV-BIOECONOMY-STRATEGY@ec.europa.eu; DEPLOYMENT.GROUP@cbe.europa.eu.
Background
The EU’s Bioeconomy Strategy aims to accelerate the transition to a circular, climate-neutral economy by scaling up the sustainable use of biological resources and strengthening Europe’s industrial base.
A key challenge remains the limited deployment of innovative bio-based solutions, often held back by high capital needs, technological risk, and fragmented access to finance.
To address this gap, the Commission is setting up a Bioeconomy Investment and Deployment Group, bringing together public and private financial actors, including the European Investment Bank, to improve coordination and mobilize investment.
The group will focus on developing a stronger pipeline of bankable projects, identifying barriers to scale-up, and supporting the uptake of bio-based innovations across sectors.
The initiative complements existing EU funding programs such as Horizon Europe and the Innovation Fund, contributing to the objectives of the European Green Deal.
Source
European Commission
We resolve the complexity of your material selection thanks to Product Data, Knowledge and Assistance.